Overview

The Use of Pecs Blocks in Combination With Exparel in Breast Reconstruction Surgery

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This project intends to more thoroughly investigate the direct influence of Pecs blocks in the administration of Exparel, a non-opioid analgesic, in breast reconstruction surgery. The hypothesis is that this analgesic delivery method will significantly reduce negative outcomes such as post-operative pain, opioid use, and nausea while increasing positive outcomes such as post-operative physical activity.
Phase:
Phase 3
Details
Lead Sponsor:
Northwestern University
Collaborator:
Pacira Pharmaceuticals, Inc
Treatments:
Bupivacaine
Lidocaine